CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Hoge Stephen President | Exercise or conversion 10b5-1 | +2,411 | 1,515,844 | ||
| 2024-02-28 | Hoge Stephen President | Exercise or conversion 10b5-1 | +2,442 | 1,518,286 | ||
| 2024-02-28 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,411 | 0 | ||
| 2024-02-28 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,442 | 7,326 | ||
| 2024-02-27 | Mock James M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +23,635 | 23,635 | ||
| 2024-02-27 | Mock James M Chief Financial Officer | Grant or award · Restricted Stock Units | +12,377 | 12,377 | ||
| 2024-02-27 | Mock James M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,216 | 60,216 | ||
| 2024-02-27 | Mock James M Chief Financial Officer | Grant or award · Restricted Stock Units | +5,304 | 5,304 | ||
| 2024-02-27 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +23,635 | 23,635 | ||
| 2024-02-27 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Restricted Stock Units | +12,377 | 12,377 | ||
| 2024-02-27 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +60,216 | 60,216 | ||
| 2024-02-27 | Klinger Shannon Thyme Chief Legal Officer | Grant or award · Restricted Stock Units | +10,609 | 10,609 | ||
| 2024-02-27 | Hoge Stephen President | Grant or award · Stock Option (Right to Buy) | +43,894 | 43,894 | ||
| 2024-02-27 | Hoge Stephen President | Grant or award · Restricted Stock Units | +22,987 | 22,987 | ||
| 2024-02-27 | Bancel Stephane Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +151,943 | 151,943 | ||
| 2024-02-22 | Hoge Stephen President | Sale 10b5-1 | −15,000 | $100.00 | $1.5M | 1,513,433 |
| 2024-02-16 | Hoge Stephen President | Sale 10b5-1 | −10,542 | $88.88 | $937K | 1,528,433 |
| 2024-02-16 | Bancel Stephane Chief Executive Officer | Sale 10b5-1 | −26,351 | $88.88 | $2.3M | 5,460,224 |
| 2024-02-14 | Hoge Stephen President | Grant or award 10b5-1 | +22,694 | 1,538,975 | ||
| 2024-02-14 | Bancel Stephane Chief Executive Officer | Grant or award 10b5-1 | +56,736 | 5,486,575 |
Page 35 of 38 · 743 trades